about
Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patientsAnti-diabetic formulations of Nāga bhasma (lead calx): A brief reviewThree-dimensional micro computed tomography analysis of the lung vasculature and differential adipose proteomics in the Sugen/hypoxia rat model of pulmonary arterial hypertensionω-6 lipids regulate PPAR turnover via reciprocal switch between PGC-1 alpha and ubiquitinationPeroxisome proliferator-activated receptor delta regulation of miR-15a in ischemia-induced cerebral vascular endothelial injuryIdentifying plausible adverse drug reactions using knowledge extracted from the literatureCalcific aortic valve stenosis: methods, models, and mechanismsHypaphorine Attenuates Lipopolysaccharide-Induced Endothelial Inflammation via Regulation of TLR4 and PPAR-γ Dependent on PI3K/Akt/mTOR Signal Pathway.Vascular smooth muscle cell-selective peroxisome proliferator-activated receptor-gamma deletion leads to hypotensionVascular smooth muscle cell peroxisome proliferator-activated receptor-γ deletion promotes abdominal aortic aneurysmsPeroxisome proliferator-activated receptors for hypertension.Thiazolidinediones up-regulate insulin-like growth factor-1 receptor via a peroxisome proliferator-activated receptor gamma-independent pathway.Vascular smooth muscle cell peroxisome proliferator-activated receptor-γ mediates pioglitazone-reduced vascular lesion formationCortical neurons develop insulin resistance and blunted Akt signaling: a potential mechanism contributing to enhanced ischemic injury in diabetes.Peroxisome proliferator-activated receptor gamma induces apoptosis and inhibits autophagy of human monocyte-derived macrophages via induction of cathepsin L: potential role in atherosclerosis.Hypoxia induces downregulation of PPAR-γ in isolated pulmonary arterial smooth muscle cells and in rat lung via transforming growth factor-β signaling.Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease.Congenital hepatic fibrosis in autosomal recessive polycystic kidney disease.Vascular PPARδ protects against stroke-induced brain injury.Association of exposure to di-2-ethylhexylphthalate replacements with increased blood pressure in children and adolescents.Transforming growth factor beta 1 induced endothelin-1 release is peroxisome proliferator-activated receptor gamma dependent in A549 cellsPeroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions.Evodiamine Attenuates PDGF-BB-Induced Migration of Rat Vascular Smooth Muscle Cells through Activating PPARγ.Nelfinavir suppresses insulin signaling and nitric oxide production by human aortic endothelial cells: protective effects of thiazolidinedionesKLF11 mediates PPARγ cerebrovascular protection in ischaemic stroke.PPARδ agonist GW501516 inhibits PDGF-stimulated pulmonary arterial smooth muscle cell function related to pathological vascular remodelingInterleukin-19 induces angiogenesis in the absence of hypoxia by direct and indirect immune mechanismsIsoliquiritigenin Attenuates Atherogenesis in Apolipoprotein E-Deficient MiceKinase-SUMO networks in diabetes-mediated cardiovascular disease.Rosiglitazone Attenuated Endothelin-1-Induced Vasoconstriction of Pulmonary Arteries in the Rat Model of Pulmonary Arterial Hypertension via Differential Regulation of ET-1 Receptors.Peroxisome proliferator-activated receptors and atherosclerosis.Peroxisome proliferator-activated receptor-γ and the endothelium: implications in cardiovascular disease.Nutrigenetics of the lipoprotein metabolism.Peroxisome proliferator-activated receptor gamma (PPAR-γ) and neurodegenerative disorders.Cytoprotective signaling and gene expression in endothelial cells and macrophages-lessons for atherosclerosis.Endothelial dysfunction and cardiac allograft vasculopathy.PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-β/δ and PPAR-γ.Antihypertensive effects of peroxisome proliferator-activated receptor-β/δ activation.Pathophysiology of Aortic Stenosis and Mitral Regurgitation.FGF1 - a new weapon to control type 2 diabetes mellitus.
P2860
Q21202033-A9893F0E-A129-497F-9C65-AC52D02FD186Q26851404-4952701B-DE93-47E3-B2AA-5FB96CAC1D1EQ28359603-BFDAE8DA-47A3-48E5-9686-290D6533F786Q28568693-AA50AE50-2EFE-4ED4-ACB5-192A61D04368Q28593367-0A770AD1-55D8-4C76-98C4-7653172B54A9Q28650098-FA4761E6-D79D-4695-BF5D-B16469B37B46Q30503246-EF6CED1B-97CF-4568-B762-EDACB4552A5BQ33624829-E232B128-34FC-43B2-9304-8B9E827E18EFQ33692662-A5691C72-0232-4C40-8866-D35CF152389FQ34172757-20787D73-05CD-4A33-80CF-E87D055ECCD5Q34179017-A3BE0C16-DE27-4C93-9141-B2074AB3F6FFQ34299000-3D633921-E6D0-4851-BFAD-318C0FC02F8EQ34796331-2361B3D6-ED10-4872-9921-40C6D296A26DQ34805939-AFD9ABA4-B772-4111-8232-374B46BB76C3Q35309535-D3ECFB45-A9DB-43B5-BB1E-96B71B8FEDADQ35601455-967D81F5-C86C-41C3-83EB-C47F2811096BQ35636191-3CB9F4C0-4DFE-4B6E-99E0-E9AFE0876135Q35655072-6C957A5D-695A-4D09-A5E4-D65E5ABE7F22Q35795489-5470E77F-362F-4937-AE06-A1AC4248F0AAQ35844648-5AD655C7-EEE5-4197-BD15-5093F44CDAD8Q36049930-B260E6F6-F847-443A-BA8E-ECDCF6BAFB24Q36261125-4A74AD83-A6DC-4005-8850-D63AE82F9309Q36403955-F62E68A8-CFA6-431D-93D8-3F29D57B1CA5Q36701580-D77F1279-D07C-4425-9521-1C3D15A06826Q36732823-B8FAC90D-CEC3-415C-A8E5-403F7233D225Q36763454-1E0322A0-ADB6-4485-8C17-3D8133907CE2Q37070979-4B26A0BC-C4A9-44A9-837C-023910573355Q37465715-9461A3B1-DFE9-4FE9-959C-56AD6701FD1AQ37579929-9367BCC4-9A8E-48A8-A609-7656335C518FQ37632333-6E751DC3-301B-4057-88FB-B18DA9E86034Q37861955-E24D04F5-4771-40AF-95B6-3DAA9F0B8B77Q37943863-8B728DDF-FA51-4078-9F43-872536FF9322Q37961647-DB750AA9-01E7-41A0-88AA-AD1975B14604Q37995569-288EEFD2-7E54-4873-AB4E-BCFD60EDAD89Q38057357-09F365FB-DD72-4095-B926-1FC89BAD291CQ38058477-394A3D2C-9B50-499F-9978-D7926DE80B55Q38674739-83DA32A3-C2E4-4C4C-8E5F-687C47C61C70Q39018398-A7812171-8FDA-4D33-8C62-594F79255A34Q39390979-78ED7537-5F74-4FF6-8B66-280D5DDD329CQ39406663-4D9D23F1-300B-4008-B60A-6E5962118D15
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
PPARs and the cardiovascular system
@ast
PPARs and the cardiovascular system
@en
PPARs and the cardiovascular system
@nl
type
label
PPARs and the cardiovascular system
@ast
PPARs and the cardiovascular system
@en
PPARs and the cardiovascular system
@nl
prefLabel
PPARs and the cardiovascular system
@ast
PPARs and the cardiovascular system
@en
PPARs and the cardiovascular system
@nl
P2093
P2860
P3181
P356
P1476
PPARs and the cardiovascular system
@en
P2093
Jifeng Zhang
Milton Hamblin
Y Eugene Chen
P2860
P304
P3181
P356
10.1089/ARS.2008.2280
P407
P50
P577
2009-06-01T00:00:00Z